Everest BioPharma International Inc.

Soon to be the seventh Health Canada independent Cannabis processing/extraction license in Canada

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Kelowna, BC, Canada
  • Currency CAD
  • Founded May 2017
  • Employees 2
  • Incorporation Type C-corp
  • Website http://everestbiopharma.ca

Company Summary

Everest BioPharma International Inc. (the “Company”) is a tightly held BC private Company, (approximately 90% of the company owned and controlled by the co-founders Nigel Boast and Rob Hatch.
On April 8, 2019 Everest received notice of Health Canada's “Confirmation of Readiness” for a Standard Processing Licence-the authority to build. A major portion of the internal buildout is completed and is now seeking the funds to complete the build out.

Team

  • Nigel Boast
    President & CEO

    Mr. Boast is a Director and co-founder of Everest. Nigel is a Canadian Citizen and a resident of Kelowna for the last 23 years. Nigel has the following academic qualifications: BSc., (zoology and biochemistry), LLB, and an MBA from the Australian Graduate School of Business.

  • ROBERT HATCH
    COO

    Mr. Hatch is a Director and co-founder of Everest who purchased the building for Everest’s operations. Robert, a resident of Kelowna for the last 13 years, graduated with a BSc. (Hons) Technology (Major) with Marketing (Minor), from the University of Central Lancashire, Preston, UK.

  • Nigel Boast

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free